Early predictors of functional disability in Guillain-Barre Syndrome

被引:17
作者
Tunc, Abdulkadir [1 ]
机构
[1] Sakarya Univ, Sakarya Training & Res Hosp, Neurol Clin, Sakarya, Turkey
关键词
Guillain-Barre syndrome; Predictors of outcome; Hughes disability score; Marker; MULTIPLE-SCLEROSIS; LYMPHOCYTE RATIO; ALBUMIN; LEVEL; HYPONATREMIA; PATHOGENESIS; DIAGNOSIS; PROGNOSIS; SEVERITY; PROTEIN;
D O I
10.1007/s13760-019-01133-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study investigated the predictors of prognosis at admission and after the first month in Guillain-Barre syndrome (GBS) patients. This retrospective study used the electronic records of 81 GBS patients. Age, gender, previous GBS history, antecedent febrile illness and presence of cranial nerve dysfunction were recorded. Detailed neurological examinations, routine biochemical and haematological investigations, cerebrospinal fluid (CSF) analysis and electrophysiological studies, GBS subtypes and treatments were assessed. Hughes disability scores (HDSs) were evaluated at the end of the first day and first month. The GBS patient group included 44 male (54.3%) and 37 female (45.7%) patients. The mean age was 52.2 +/- 18.5. The mean HDS score was 2.96 at admission and 1.94 at the end of the first month. Plasma sodium, albumin, and CSF protein levels were significantly correlated with low admission HDS scores (p=0.03, p =0.011, p =0.036, and p <0.001, respectively). Age, plasma sodium, albumin, neutrophil, neutrophil/lymphocyte ratio (NLR) levels, C-reactive protein (CRP) and CSF protein levels were significantly correlated with poor prognosis at the end of the first month (p<0.05). Concomitant cranial nerve palsies were significantly correlated with low HDS scores (p=0.011, p=0.02) but antecedent events were not correlated with functional disability (p=0.686, p=0.413). Decreased albumin and sodium levels and increased CSF protein levels indicated poor GBS prognosis. Higher age, elevated NLR, and higher CRP levels indicated worse prognosis at the end of the first month. However, further studies are needed.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 31 条
  • [11] Autoimmune T cell responses in the central nervous system
    Goverman, Joan
    [J]. NATURE REVIEWS IMMUNOLOGY, 2009, 9 (06) : 393 - 407
  • [12] Electrophysiological classification of Guillain-Barre syndrome: Clinical associations and outcome
    Hadden, RDM
    Cornblath, DR
    Hughes, RAC
    Zielasek, J
    Hartung, HP
    Toyka, KV
    Swan, AV
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (05) : 780 - 788
  • [13] Hyponatraemia in Guillain-Barre syndrome revisited
    Hiew, F. L.
    Winer, J. B.
    Rajabally, Y. A.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (04): : 295 - 301
  • [14] Thyroid hormone level is associated with the frequency and severity of Guillain-Barre syndrome
    Huang, Yuanyuan
    Ying, Zhaojian
    Chen, Zhibo
    Xiang, Weiwei
    Su, Zhongqian
    Quan, Weiwei
    Weng, Yiyun
    Zhang, Xu
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (10) : 893 - 899
  • [15] CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
    HUGHES, RAC
    NEWSOMDAVIS, JM
    PERKIN, GD
    PIERCE, JM
    [J]. LANCET, 1978, 2 (8093) : 750 - 753
  • [16] Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barre syndrome
    Kerasnoudis, Antonios
    Pitarokoili, Kalliopi
    Behrendt, Volker
    Gold, Ralf
    Yoon, Min-Suk
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 37 - 43
  • [17] Lobo SM, 2012, CRIT CARE, V16, DOI [10.1186/cc11347, 10.1186/CC11347]
  • [18] Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barre syndrome
    Ozdemir, Hasan Huseyin
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (09) : 718 - 722
  • [19] Outcome and its predictors in Guillain-Barre syndrome
    Rajabally, Yusuf A.
    Uncini, Antonino
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (07) : 711 - 718
  • [20] Sahin S, 2017, NEUROL INT, V9, P21, DOI 10.4081/ni.2017.7032